Clinical Trials Sponsored by Rana McKay, MD
Total 112 results
-
Rana McKay, MDBristol-Myers Squibb; ExelixisRecruitingMetastatic Cancer | Castration-resistant Prostate CancerUnited States
-
Rana McKay, MDUniversity of California, San Diego; AstraZenecaRecruitingProstate Cancer | BRCA1 Mutation | BRCA2 Mutation | Prostatic Adenocarcinoma | High-Risk CancerUnited States
-
Dana Portenier, MDAllerganTerminatedMorbid ObesityUnited States
-
Patrick Ott, MDCompleted
-
Allison O'Neill, MDRecruitingLiver Cancer | Fibrolamellar Carcinoma | Hepatocellular Carcinoma, Childhood | Liver Cancer, PediatricUnited States
-
Toni Choueiri, MDWithdrawnAdenocarcinoma of the ProstateUnited States
-
Ana C Garrido-Castro, MDMerck Sharp & Dohme LLC; Gilead SciencesActive, not recruitingMetastatic Breast Cancer | Invasive Breast Cancer | HER2-negative Breast Cancer | HR-Positive Breast CancerUnited States
-
Eric Stephen Winer, MDRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2United States
-
Jacqueline Garcia, MDAbbVieRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelofibrosis | Myeloid Malignancy | Myeloproliferative NeoplasmUnited States
-
Shayna Sarosiek, MDAstraZenecaRecruitingWaldenstrom Macroglobulinemia | Neuropathy;Peripheral | IgM MGUSUnited States
-
Reza Dana, MDCompletedCorneal Neovascularization | Corneal Graft FailureUnited States
-
Reza Dana, MDCompletedCorneal NeovascularizationUnited States
-
Marlise Luskin, MDNovartisRecruitingB-cell Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALLUnited States
-
Kimberly Perez, MDNovartisTerminatedPancreatic Cancer | Pancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Borderline Resectable Pancreatic AdenocarcinomaUnited States
-
Mary-Ellen Taplin, MDCompletedProstate CancerUnited States
-
Reza Dana, MDCompletedCorneal NeovascularizationUnited States
-
Omar Nadeem, MDTakedaRecruitingMultiple Myeloma | Multiple Myeloma in RelapseUnited States
-
Jacob Laubach, MDSanofiActive, not recruitingMultiple Myeloma | Autologous Stem Cell Transplant | Newly Diagnosed Multiple Myeloma (NDMM)United States
-
Reza Dana, MDCompletedPosterior Blepharitis
-
Reza Dana, MDTerminatedCorneal NeovascularizationUnited States
-
Sarah Sammons, MDDaiichi SankyoRecruitingBreast Cancer | Breast Cancer Female | Metastatic Triple-Negative Breast Carcinoma | HER2-negative Breast Cancer | HER2 Negative Breast Carcinoma | ER-negative Breast Cancer | ER Positive Breast CancerUnited States
-
Omar Nadeem, MDJanssen, LPRecruitingMultiple Myeloma | High-risk Smoldering Multiple MyelomaUnited States
-
Julia K. Rotow, MDInivataActive, not recruitingMetastatic Non-Small Cell Lung Cancer | NSCLC Stage IVUnited States
-
Antonio Giordano, MDCardiff OncologyRecruitingBreast Cancer | Metastatic Breast Cancer | Inflammatory Breast Cancer | Invasive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | HER2-negative Breast Cancer | Triple Negative Breast Cancer (TNBC) | Hormone Receptor Negative Breast Carcinoma | Hormone Receptor/Growth Factor...United States
-
Otto Metzger, MDGenentech, Inc.Active, not recruitingMetastatic Breast Cancer | Recurrent Breast CancerUnited States
-
Bradley A. McGregor, MDPfizerWithdrawnAdvanced Clear Cell Renal Cell CarcinomaUnited States
-
Jeffrey Zwicker, MDQuercegen PharmaceuticalsWithdrawnSickle Cell Disease | Sickle Cell-Beta0-Thalassemia
-
Maximilian Stahl, MDSyndax PharmaceuticalsNot yet recruitingAcute Myeloid Leukemia | Leukemia | AML | AML, Adult | AML With Gene MutationsUnited States
-
Jennifer Crombie, MDGenentech, Inc.RecruitingLymphoma | Lymphoma, Large B-Cell, DiffuseUnited States
-
Reid Merryman, MDAbbVie; GenmabRecruitingFollicular Lymphoma | Low Grade Non-Hodgkin's Lymphoma, AdultUnited States
-
Reid Merryman, MDGenentech, Inc.RecruitingFollicular Lymphoma | Marginal Zone Lymphoma | Indolent Non-hodgkin LymphomaUnited States
-
Jonathan Schoenfeld, MD, MPHNaverisRecruitingHPV Positive Oropharyngeal Squamous Cell Carcinoma | Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC... and other conditionsUnited States
-
Elizabeth Buchbinder, MDGenentech, Inc.RecruitingStage IV Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Unresectable Stage III Cutaneous Melanoma | Unresectable Stage IV Cutaneous MelanomaUnited States
-
Nancy Lin, MDGenentech, Inc.Active, not recruitingHER2-positive Metastatic Breast Cancer | Central Nervous System MetastasesUnited States
-
Nancy Lin, MDGlaxoSmithKline; NovartisActive, not recruitingBreast CancerUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
F. Stephen Hodi, MDMedImmune LLCCompletedMetastatic MelanomaUnited States
-
Shayna Sarosiek, MDADC Therapeutics S.A.Recruiting
-
Lakshmi Nayak, MDKazia Therapeutics LimitedRecruitingPrimary Central Nervous System Lymphoma | Non-Hodgkin Lymphoma of Extranodal SiteUnited States
-
Patrick Wen, MDBristol-Myers SquibbActive, not recruitingGlioblastoma | Glioblastoma Multiforme | GBM | Grade IV AstrocytomaUnited States
-
Toni Choueiri, MDBristol-Myers SquibbActive, not recruitingRenal CancerUnited States
-
Crouse HospitalJana Shaw, MD; Steven Gross, MD; David Martin, RN; Dale Franz, RPh; Rachel CareyCompletedStaphylococcusUnited States
-
Jennifer Crombie, MDMerck Sharp & Dohme LLCRecruitingPrimary Mediastinal Large B-cell Lymphoma (PMBCL) | Primary Mediastinal Large B Cell Lymphoma | T-Cell/Histiocyte-Rich Large B-Cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma Refractory | Primary Mediastinal Large B-Cell Lymphoma Recurrent | Epstein-Barr Virus Positive Diffuse Large...United States
-
Nadine McCleary, MD, MPHBristol-Myers SquibbRecruitingThoracic Cancer | Gastrointestinal Cancer | Hematologic CancerUnited States
-
Bradley A. McGregor, MDCalithera Biosciences, IncCompletedRenal Cell CarcinomaUnited States
-
Xiao X. Wei, MDBristol-Myers SquibbActive, not recruitingProstate Adenocarcinoma | Hormone Sensitive Prostate Cancer | Metastasis Prostate AdenocarcinomaUnited States
-
Jorge J. Castillo, MDBristol-Myers SquibbTerminated
-
Kimberly Perez, MDEli Lilly and CompanyCompleted
-
Jiping Wang, MD, PhDAstraZeneca; Sirtex MedicalRecruitingHepatocellular Carcinoma | Hepatocellular Cancer | Resectable Hepatocellular CarcinomaUnited States
-
Jacqueline Garcia, MDEli Lilly and CompanyCompletedCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaRelapsed Adult Acute Myeloid Leukemia | Refractory Adult Acute Myeloid LeukemiaUnited States